Netscientific PLC (NSCI) Stock Rating Reaffirmed by Stifel Nicolaus
Netscientific PLC (LON:NSCI)‘s stock had its “buy” rating reissued by research analysts at Stifel Nicolaus in a research report issued on Tuesday. They currently have a GBX 95 ($1.25) price target on the stock. Stifel Nicolaus’ price target suggests a potential upside of 46.38% from the stock’s previous close.
Shares of Netscientific PLC (LON:NSCI) opened at GBX 64.90 ($0.85) on Tuesday. Netscientific PLC has a 12 month low of GBX 36 ($0.47) and a 12 month high of GBX 73.80 ($0.97).
Netscientific PLC (LON:NSCI) last issued its quarterly earnings data on Thursday, September 28th. The company reported GBX (8.80) (($0.12)) earnings per share for the quarter. Netscientific PLC had a negative return on equity of 51.79% and a negative net margin of 3,144.51%. The company had revenue of GBX 16 million for the quarter.
Netscientific PLC Company Profile
NetScientific plc is a transatlantic healthcare technology company. The Company develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in the United States and Europe with a primary focus on diagnostics, digital health and therapeutics.
Receive News & Ratings for Netscientific PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Netscientific PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.